• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

STIMULATE-ICP ( Long Covid Study)

marcjf

Senior Member
Messages
128
The STIMULATE-ICP (https://www.stimulate-icp.org/) will be a 2-year study, starting on the fall, investigating causes and treatments for Long Covid.

It seems they are looking into three different treatments to trial:
* anticoagulant rivaroxaban;
* anti-inflammatory drug colchicine;
* antihistamine combination of famotidine and loratadine;

The only treatment I have not heard about is Rivaroxaban. Any thoughts on that? I heard about other anti-coagulants being used in CFS patients though.
 
Back